Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.920
-0.020 (-1.03%)
At close: Jan 16, 2026
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 26.55 billion as of January 16, 2026. Its market cap has decreased by -25.77% in one year.
Market Cap
26.55B
Enterprise Value
25.53B
Revenue
5.28B
Ranking
n/a
PE Ratio
1,595.60
Stock Price
1.92
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 26.55B, an increase of 929.71%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 26.55B | 0.52% |
| Dec 31, 2025 | 26.41B | -18.58% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 412.15B |
| WuXi AppTec | 311.06B |
| Shenzhen Mindray Bio-Medical Electronics | 243.32B |
| Sichuan Biokin Pharmaceutical | 130.12B |
| Shanghai United Imaging Healthcare | 112.20B |
| Aier Eye Hospital Group | 105.78B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.78B |
| Yunnan Baiyao Group Co.,Ltd | 100.28B |